Press Release

Burns & Levinson represented client BTR (Boston Technology Research Corporation), a regulatory technology company serving healthcare, life sciences and SaMD, in a $15 million Series A Preferred financing round led by New York-based global venture capital and private equity firm Insight Partners, with participation from existing investors LRV Health, NewStack Ventures and others. The new funding will be used to ensure that BTR’s customers are prepared for the FDA’s anticipated guidance that will incentivize a move from traditional methods to new technologies.

“The team at Burns & Levinson have been true partners and have added value to every facet of our business,” said Bryan Ennis, BTR CEO. “Their depth of expertise and thoughtful advice have helped us accelerate our growth and the support with our Series A raise was particularly critical. We are thankful for their trusted legal counsel.”